Gastroenterology

If Crohn’s disease patients need steroids and immuno-modulators on top of the tumour necrosis factor inhibitor adalimumab, the risk of serious infection is increased, according to a pooled analysis of five clinical trials. The research was presented at the American College of Gastroenterology annual meeting here.

The OTC management of GERD.

Emotional reaction to examinations should prompt query

Researchers find high success rates with stool from healthy donors

Patients with long-term inflammatory bowel disease (IBD) may need to be tested for serrated adenomas, researchers said at the ACG meeting.

Patients who get their prescribed injections stay out of hospital

Dietary intervention can have big impact on common problem